SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ALKS - Alkermes, Inc.
ALKS 28.49-0.1%Dec 26 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (161)5/21/2006 6:12:55 PM
From: rkrw  Read Replies (2) of 189
 
I asked for your est of peak sales, what you considered a commercial dud for vivitrol, not your take on year one guidance. Kind of lame to criticize their guidance but not answer the question.

My personal opinion is I'd call $300M/year pretty successful. High margin, low marketing cost, that would make it a nice and profitable product. Not every drug has to be a blockbuster to be considered a success.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News